{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:22:01Z","timestamp":1794036121790,"version":"4.8.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006537","name":"Campus France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejmech.2024.116720","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:16:13Z","timestamp":1722039373000},"page":"116720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Emerging therapeutics: The imidazo[1,2-b]pyridazine scaffold as a novel drug candidate for eumycetoma, a neglected tropical disease"],"prefix":"10.1016","volume":"277","author":[{"given":"Lamis Yahia Mohamed","family":"Elkheir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Delaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Penichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Eadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi Awadalla","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Besson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e9la\u00efde","family":"Chesnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Desoubeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Wilhelmina Johanna","family":"van de Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Hassan","family":"Fahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4220-7160","authenticated-orcid":false,"given":"C\u00e9cile","family":"Enguehard-Gueiffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116720_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/ced.13642","article-title":"Mycetoma: reviewing a neglected disease","volume":"44","author":"Verma","year":"2019","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ejmech.2024.116720_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002550","article-title":"Global burden of human mycetoma: a systematic review and meta-analysis","volume":"7","author":"van de Sande","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ejmech.2024.116720_bib3","unstructured":"Neglected tropical diseases \u2013 GLOBAL, https:\/\/www.who.int\/health-topics\/neglected-tropical-diseases#tab=tab_1."},{"key":"10.1016\/j.ejmech.2024.116720_bib4","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/jdv.13008","article-title":"Eumycetoma and actinomycetoma \u2013 an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy","volume":"29","author":"Nenoff","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejmech.2024.116720_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002667","article-title":"The mycetoma knowledge gap: identification of research priorities","volume":"8","author":"van de Sande","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116720_bib6","first-page":"97","article-title":"Mycetoma: the spectrum of clinical presentation","volume":"3","author":"Fahal","year":"2018","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116720_bib7","first-page":"31","article-title":"Mycetoma: epidemiology, treatment challenges, and progress","volume":"31","author":"van de Sande","year":"2015","journal-title":"Res. Rep. Trop. Med."},{"key":"10.1016\/j.ejmech.2024.116720_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008307","article-title":"Madurella mycetomatis causing eumycetoma medical treatment: the challenges and prospects","volume":"14","author":"Elkheir","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116720_bib9","unstructured":"FDA Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems | FDA. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-limits-usage-nizoral-ketoconazole-oral-tablets-due-potentially."},{"key":"10.1016\/j.ejmech.2024.116720_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005007","article-title":"Predictors of post-operative mycetoma recurrence using machine-learning algorithms: the mycetoma research center experience","volume":"10","author":"Wadal","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116720_bib11","first-page":"1","article-title":"Clinical hepatotoxicity associated with antifungal agents","volume":"16","author":"Kyriakidis","year":"2016","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejmech.2024.116720_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006437","article-title":"Addressing the most neglected diseases through an open research model: the discovery of fenarimols as novel drug candidates for eumycetoma","volume":"12","author":"Lim","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116720_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010159","article-title":"Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma","volume":"16","author":"Lim","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116720_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/trstmh\/traa184","article-title":"In vitro susceptibility testing for black grain eumycetoma causative agents","volume":"115","author":"van De Sande","year":"2021","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2024.116720_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/mmy\/myx064","article-title":"Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatis","volume":"56","author":"Kloezen","year":"2018","journal-title":"Med. Mycol."},{"key":"10.1016\/j.ejmech.2024.116720_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.trstmh.2010.11.008","article-title":"The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis","volume":"105","author":"Fahal","year":"2011","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2024.116720_bib18","first-page":"20.4.1","article-title":"Neutral red uptake cytotoxicity tests for estimating starting doses for acute oral toxicity tests","volume":"36","author":"Stokes","year":"2008","journal-title":"Curr. Protoc. Toxicol."},{"key":"10.1016\/j.ejmech.2024.116720_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003926","article-title":"A Madurella mycetomatis grain model in Galleria mellonella larvae","volume":"9","author":"Kloezen","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116720_bib20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/bjd.14025","article-title":"Amphotericin B but not itraconazole is able to prevent grain formation in experimental Madurella mycetomatis mycetoma in mice","volume":"173","author":"van de Sande","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejmech.2024.116720_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/acscombsci.6b00111","article-title":"Synthesis of pyridazine-based \u03b1-helix mimetics","volume":"18","author":"Londregan","year":"2016","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.ejmech.2024.116720_bib22","doi-asserted-by":"crossref","first-page":"10414","DOI":"10.1021\/jm301367c","article-title":"Rational design of highly selective spleen tyrosine kinase inhibitors","volume":"55","author":"Lucas","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116720_bib23","doi-asserted-by":"crossref","first-page":"19701","DOI":"10.1021\/acsami.9b22060","article-title":"Imidazo[1,2-b]pyridazine as building blocks for host materials for high-performance red-phosphorescent organic light-emitting devices","volume":"12","author":"Song","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejmech.2024.116720_bib24","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.49.4.1364-1368.2005","volume":"49","author":"van de Sande","year":"2005","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424006019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424006019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T12:12:12Z","timestamp":1738411932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424006019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":23,"alternative-id":["S0223523424006019"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116720","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging therapeutics: The imidazo[1,2-b]pyridazine scaffold as a novel drug candidate for eumycetoma, a neglected tropical disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116720"}}